Literature DB >> 19640345

History of islet transplantation.

Benigno J Digon1.   

Abstract

Patients with a diagnosis of type 1 diabetes mellitus endure stringent life-long medical therapy through the use of insulin to prevent end organ complications and maintain normoglycemia. However, some patients still suffer from hypoglycemic unawareness, even under intensive therapy. Within the past decade, noble efforts have been attempted to provide normoglycemia through cadaveric islet of Langerhans transplantation in order to reach a physiologic response. This effort, which has evolved for more than a century, actually predates the discovery of insulin.

Entities:  

Mesh:

Year:  2009        PMID: 19640345     DOI: 10.1007/s11892-009-0048-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  26 in total

Review 1.  State of the art: islet transplantation for the cure of type 1 diabetes mellitus.

Authors:  Boaz Hirshberg; Kristina I Rother; Benigno J Digon III; Jeffrey Venstrom; David M Harlan
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 6.514

2.  Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation.

Authors:  Muhammad M Hafiz; Raquel N Faradji; Tatiana Froud; Antonello Pileggi; David A Baidal; Pablo Cure; Gaston Ponte; Raffaella Poggioli; Agustin Cornejo; Shari Messinger; Camillo Ricordi; Rodolfo Alejandro
Journal:  Transplantation       Date:  2005-12-27       Impact factor: 4.939

3.  Standards of medical care in diabetes--2008.

Authors: 
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

4.  Morphometrical analysis on topographical difference in size distribution, number and volume of islets in the human pancreas.

Authors:  K Saito; N Iwama; T Takahashi
Journal:  Tohoku J Exp Med       Date:  1978-02       Impact factor: 1.848

5.  Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats.

Authors:  C B Kemp; M J Knight; D W Scharp; W F Ballinger; P E Lacy
Journal:  Diabetologia       Date:  1973-12       Impact factor: 10.122

6.  Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion.

Authors:  J R Lakey; G L Warnock; A M Shapiro; G S Korbutt; Z Ao; N M Kneteman; R V Rajotte
Journal:  Cell Transplant       Date:  1999 May-Jun       Impact factor: 4.064

7.  International trial of the Edmonton protocol for islet transplantation.

Authors:  A M James Shapiro; Camillo Ricordi; Bernhard J Hering; Hugh Auchincloss; Robert Lindblad; R Paul Robertson; Antonio Secchi; Mathias D Brendel; Thierry Berney; Daniel C Brennan; Enrico Cagliero; Rodolfo Alejandro; Edmond A Ryan; Barbara DiMercurio; Philippe Morel; Kenneth S Polonsky; Jo-Anna Reems; Reinhard G Bretzel; Federico Bertuzzi; Tatiana Froud; Raja Kandaswamy; David E R Sutherland; George Eisenbarth; Miriam Segal; Jutta Preiksaitis; Gregory S Korbutt; Franca B Barton; Lisa Viviano; Vicki Seyfert-Margolis; Jeffrey Bluestone; Jonathan R T Lakey
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

8.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

9.  A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes.

Authors:  Garth L Warnock; David M Thompson; R Mark Meloche; R Jean Shapiro; Ziliang Ao; Paul Keown; James D Johnson; C Bruce Verchere; Nilufar Partovi; Iain S Begg; Michelle Fung; Sharon E Kozak; Suet On Tong; Khalid M Alghofaili; Claire Harris
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

10.  Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.

Authors:  E H Liu; B J Digon; B Hirshberg; R Chang; B J Wood; Z Neeman; A Kam; R A Wesley; S M Polly; R M Hofmann; K I Rother; D M Harlan
Journal:  Diabetologia       Date:  2009-05-06       Impact factor: 10.122

View more
  2 in total

1.  Effect of the Duration of Chronic Pancreatitis on Pancreas Islet Yield and Metabolic Outcome Following Islet Autotransplantation.

Authors:  Morihito Takita; Luis F Lara; Bashoo Naziruddin; Rauf Shahbazov; Michael C Lawrence; Peter T Kim; Nicholas Onaca; James S Burdick; Marlon F Levy
Journal:  J Gastrointest Surg       Date:  2015-05-02       Impact factor: 3.452

2.  A Study on the Effect of Patient Characteristics, Geographical Utilization, and Patient Outcomes for Total Pancreatectomy Alone and Total Pancreatectomy With Islet Autotransplantation in Patients With Pancreatitis in the United States.

Authors:  Luis F Lara; Melena D Bellin; Emmanuel Ugbarugba; Jaimie D Nathan; Piotr Witkowski; Martin Wijkstrom; Jennifer L Steel; Kerrington D Smith; Vikesh K Singh; Sarah J Schwarzenberg; Timothy L Pruett; Bashoo Naziruddin; Leslie Long-Simpson; Varvara A Kirchner; Timothy B Gardner; Martin L Freeman; Ty B Dunn; Srinath Chinnakotla; Gregory J Beilman; David B Adams; Katherine A Morgan; Maisam A Abu-El-Haija; Syed Ahmad; Andrew M Posselt; Michael G Hughes; Darwin L Conwell
Journal:  Pancreas       Date:  2019-10       Impact factor: 3.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.